APA (7th ed.) Citation

Lacalle-Gonzalez, C., Florez-Cespedes, M., Sanz-Criado, L., Otieno, M. O., Ramos-Muñoz, E., Fernandez-Aceñero, M. J., . . . Martinez-Useros, J. (2023). DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer. MDPI AG.

Chicago Style (17th ed.) Citation

Lacalle-Gonzalez, Carlos, Maria Florez-Cespedes, Lara Sanz-Criado, Michael Ochieng’ Otieno, Edurne Ramos-Muñoz, Maria Jesus Fernandez-Aceñero, Luis Ortega-Medina, Jesus Garcia-Foncillas, and Javier Martinez-Useros. DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer. MDPI AG, 2023.

MLA (9th ed.) Citation

Lacalle-Gonzalez, Carlos, et al. DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer. MDPI AG, 2023.